New drug combinations could improve therapies for breast cancer, other aggressive cancers

Quantification of CD8+ T cells by multispectral flow cytometry in an ex vivo co-culture assay. Credit: Cell Reports Medicine (2024). DOI: 10.1016/j.xcrm.2024.101698 Oregon Health & Science University researchers have identified a combination of treatments that show promise in slowing the progression of cancer and reducing tumor growth. Their research lays the groundwork for developing more effective treatments for triple negative breast cancers and mesotheliomas—both aggressive forms of cancer that are difficult to treat. The new study was published Friday in Cell Reports Medicine. “Current immune therapies are effective for only a small percentage of patients with these types of cancer,” Read More